Virtual Diabetes Group Visits Across Health Systems (VIDA)
T2DM (Type 2 Diabetes Mellitus), Hypertension, Heart Disease Chronic
About this trial
This is an interventional health services research trial for T2DM (Type 2 Diabetes Mellitus) focused on measuring virtual group visits
Eligibility Criteria
Inclusion Criteria: Patient at a participating clinic (at least one visit in year prior to first GV) Type 2 diabetes ≥ 18 years old A1C>8% within 6 months prior to first GV (we will first recruit patients with A1C>9%, then if spaces still available A1C>8.5%, then if spaces still available A1C>8%) At least one additional cardiovascular condition (hypertension, heart disease, stroke, hyperlipidemia, peripheral vascular disease, or BMI ≥ 30) English or Spanish speaking PCP assented to recruiting patient Patient provides written consent
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Virtual Group Visit Arm
Usual Care Arm
These subjects will attend 6 monthly virtual group visits hosted by ACCESS or Advocate research staff.
These subjects will receive usual diabetes care at ACCESS or Advocate health centers.